Pulmonary Hypertension Trial, Recruiting NCT06569940 Sponsor: Sleepiz AG Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT06569940
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You are willing to sign a consent form agreeing to take part in the study
  • You have one or more long-term health conditions (such as diabetes, asthma, heart disease, or breathing conditions) — this applies to the patient group
  • You have no diagnosed long-term health conditions — this applies to the healthy volunteer group

Who may not be able to join:

  • You have already taken part in this same study before
  • You have a cardiac pacemaker or any other implanted electrical device in your body
  • You are currently pregnant or breastfeeding
  • You are unable to follow the study instructions for any reason, such as language barriers, psychological disorders, dementia, or similar difficulties (confirm with trial site)
  • Healthy volunteers who have been diagnosed with any long-term medical condition are not eligible for the healthy volunteer group

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christian Neumann, Dr. med., Zentrum für Schlafmedizin "Schlaflabor Fluntern"

Phone: +41 44 586 08 88

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sleepiz AG
Registry
ClinicalTrials.gov
Start date
18 July 2024
Est. completion
30 September 2024

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Instantaneous respiration rate measurement accuracy per 60s epoch; Instantaneous heart rate measurement accuracy per 60s epoch

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov